Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201107319 Principal Investigator: Parikh, Parag
Title: Feasibility Study of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
Phase: Pilot Disease Site: Liver
Participating Site(s):
 
Main Campus
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study is being done to
determine if targeted radiation therapy (stereotactic) can be given to treat liver cancer over a short period of time with a small amount of side effects. Conventional radiation therapy, which does not use this high level of targeting and often takes weeks to deliver, has been the traditional form
of radiation therapy for this liver cancers.
We are studying stereotactic radiotherapy for your cancer. Stereotactic radiotherapy is referred to as "targeted radiation therapy". It uses special equipment to position the patient and guide the focused beams of radiation toward the cancer and away from normal surrounding tissue. This treatment is routinely available in the medical community and is widely covered by Medicare and other insurance companies. This newer treatment technique delivers a high dose of radiation
precisely to the cancer with the surrounding, normal liver receiving a low enough dose that this tissue should remain free from injury. We want to find out what effects, good and/or bad, it has on you and your type of liver cancer. If this therapy can be delivered safely, we will test whether it can be used to improve survival in future patients.
 
More Information:
Clinical Trials.gov
Internal Protocol Documents (requires Siteman administrative database password)